Across 4 studies, all reported beneficial effects of Bifidobacterium animalis subsp. lactis BB-12 on short-chain fatty acid production, with effect sizes ranging from small to moderate. Evidence is dominated by in vitro and methodological studies, with limited data from human trials; the most reliable evidence comes from a meta-analysis in older adults showing small beneficial effects on valeric and acetic acid levels.
Caveats: Evidence base is small (only 4 studies) — conclusions should be considered preliminary. Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Effect sizes varied from small to moderate across studies, and only 1 of 4 studies reported statistical significance. Most studies were in vitro or methodological, limiting direct human generalizability.
Synbiotic supplementation enhanced valeric acid (SMD = 0.50) and acetic acid levels (SMD = 0.62)
Both processing methods significantly increased SCFA levels (p < 0.05).
Higher contents of lactate, acetate, and butyrate and higher amylase activity were observed in RS5 compared to RS2 after fermentation.
levels of acetate, propionate, and butyrate were significantly elevated in fecal samples
Both synbiotic yogurts increased levels of beneficial organic acids, such as propionate and lactate, and decreased ammonium ion concentrations